Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a study to evaluate the efficacy and safety of deutetrabenazine (TEV-50717) tablets for the reduction of motor and phonic tics associated with TS in children and adolescents 6 through 16 years of age.
Epistemonikos ID: e5e30051aa156294f5d19d208af226c272ab16f0
First added on: May 21, 2024